Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray D Page

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Oncology Practice|July 10, 2014
Changing physician incentives for affordable, quality cancer care: results of an episode payment modelLee N Newcomer, Bruce Gould, Ray D Page, et al.
Cureus|August 24, 2023
Soft Tissue Mass Extramedullary Plasmacytoma Following Radiation Therapy for Solitary Bone PlasmacytomaJong H Kim, Ray D Page, Yen-Chung Wang, et al.
Managed Care (Langhorne, Pa.)|October 26, 2017
The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung CancerRay D Page, A Christine Argento, David B Nash, et al.
Cancer|September 24, 2005
Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinomaRay D Page, Frederick P Smith, George F Geils, et al.
Journal of Oncology Practice|November 16, 2014
Payment for oncolytics in the United States: a history of buy and bill and proposals for reformBlase N Polite, Jeffery C Ward, John V Cox, et al.
Journal of Oncology Practice|January 14, 2016
American Society of Clinical Oncology Policy Statement on Clinical Pathways in OncologyRobin T Zon, James N Frame, Michael N Neuss, et al.
JCO Oncology Practice|April 18, 2020
Updates to the ASCO Patient-Centered Oncology Payment ModelJeffrey C Ward, Brian Bourbeau, Alexander L Chin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancerVera Hirsh, Isamu Okamoto, Jeremy K Hon, et al.
Journal of Oncology Practice|February 8, 2018
Oncology Clinical Pathways: Charting the Landscape of Pathway ProvidersBobby Daly, Robin T Zon, Ray D Page, et al.
Journal of Oncology Practice|March 11, 2017
American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in OncologyRobin T Zon, Stephen B Edge, Ray D Page, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Oncology Practice|July 10, 2014
Changing physician incentives for affordable, quality cancer care: results of an episode payment modelLee N Newcomer, Bruce Gould, Ray D Page, et al.
Cureus|August 24, 2023
Soft Tissue Mass Extramedullary Plasmacytoma Following Radiation Therapy for Solitary Bone PlasmacytomaJong H Kim, Ray D Page, Yen-Chung Wang, et al.
Managed Care (Langhorne, Pa.)|October 26, 2017
The Role of Proteomic Testing in Improving Prognosis And Care Planning Quality Measures for Lung CancerRay D Page, A Christine Argento, David B Nash, et al.
Cancer|September 24, 2005
Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinomaRay D Page, Frederick P Smith, George F Geils, et al.
Journal of Oncology Practice|November 16, 2014
Payment for oncolytics in the United States: a history of buy and bill and proposals for reformBlase N Polite, Jeffery C Ward, John V Cox, et al.
Journal of Oncology Practice|January 14, 2016
American Society of Clinical Oncology Policy Statement on Clinical Pathways in OncologyRobin T Zon, James N Frame, Michael N Neuss, et al.
JCO Oncology Practice|April 18, 2020
Updates to the ASCO Patient-Centered Oncology Payment ModelJeffrey C Ward, Brian Bourbeau, Alexander L Chin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancerVera Hirsh, Isamu Okamoto, Jeremy K Hon, et al.
Journal of Oncology Practice|February 8, 2018
Oncology Clinical Pathways: Charting the Landscape of Pathway ProvidersBobby Daly, Robin T Zon, Ray D Page, et al.
Journal of Oncology Practice|March 11, 2017
American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in OncologyRobin T Zon, Stephen B Edge, Ray D Page, et al.
Pageof 4